Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results for Clostridioides difficile
Abstract Number: 125
RBX2660 IN PATIENTS AFTER FIRST RECURRENCE OF CLOSTRIDIOIDES DIFFICILE INFECTION
SHM Converge 2023
Background: Antibiotics used to treat Clostridioides difficile infection (CDI) can predispose patients to recurrent CDI (rCDI). Gut microbiome restoration by fecal microbiota transplantation is recommended by multiple guidelines after ≥2 episodes of rCDI, with no guideline-recommended options to restore the microbiome earlier in the course of CDI. RBX2660 is a standardized, microbiota-based live biotherapeutic being […]
Abstract Number: 127
24-MONTH SUSTAINED OUTCOMES OF RBX2660 FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
SHM Converge 2023
Background: Clostridioides difficile is an opportunistic pathogen that causes an estimated 500,000 infections per year in the United States. RBX2660, a standardized, microbiota-based live biotherapeutic, is being investigated as a treatment option for recurrent C. difficile infection (rCDI). RBX2660 has demonstrated consistent tolerability and efficacy in reducing rCDI across 6 clinical studies. We present a […]
Abstract Number: 291
CLOSTRIDIOIDES DIFFICILE: A RECURRENT INFECTION WITH BROAD ECONOMIC CONSEQUENCES
SHM Converge 2023
Background: Clostridioides difficile infection (CDI) is the most common health care–associated infection in the United States and has serious clinical consequences with limited data on economic impact on US hospitals. The objective of this study was to quantify the cost of hospitalizations, readmissions, and expected reimbursement for each all-cause and CDI-related hospitalization during 12 months […]
Abstract Number: 363
REDUCTION IN HOSPITAL-ACQUIRED CLOSTRIDIODES DIFFICILE THROUGH INTERDISCIPLINARY TEAM APPROACH
SHM Converge 2023
Background: Clostroidiodes difficile (CD) is the most prevalent hospital-acquired infection in the United States, accounting for approximately 224,000 infections with 13,000 deaths and over 1 billion dollars spent in 2017, according to the Centers for Disease Control and Prevention (CDC). Clostroidiodes difficile accounts for 10-20% of diarrhea in the setting of recent antibiotics exposure.In St […]
  • This Week

  • This Month

  • All Time

  • This Week

  • Cannabis Withdrawal Induced Hypertensive Urgency
  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON
  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS
  • A Patient’s Presentation of Persistent Sweet Taste in Her Mouth Leads to a Diagnosis of Small Cell Lung Cancer
  • This Month

  • Cannabis Withdrawal Induced Hypertensive Urgency
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON
  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS
  • All Time

  • ADDERALL INDUCED ISCHEMIC COLITIS
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • PECULIAR PRESENTATION OF VERTIGO IN HYPOTHYROIDISM
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
© Society of Hospital Medicine | All Rights Reserved
Page load link
Go to Top